Plain-English translation of NCT05046080 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study that looks back at the medical records and tumor tissue of patients who have been treated for clear cell carcinoma of the cervix — a very rare type of cervical cancer. Researchers will analyze the tissue samples using specialized laboratory tests to understand the cancer's characteristics and genetic makeup. This information may help doctors better understand and treat this uncommon cancer in the future.
Clear cell carcinoma of the cervix is extremely rare, and doctors don't know as much about it as they do about other cervical cancers. By studying the tissue and medical records of patients who have had this cancer, researchers hope to learn more about what causes it and how it behaves, which could eventually lead to better treatment options.
You likely qualify if…
You likely don't qualify if…
Your participation involves allowing researchers to review your medical records from M.D. Anderson Cancer Center and to study your archived tumor tissue samples using laboratory tests. There are no clinic visits, treatments, or ongoing commitments required — the research team does all the work by examining existing information and tissue samples that were already collected as part of your care.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States
Sponsor
M.D. Anderson Cancer Center
Enrollment target
~70 participants
Started
August 2021
Primary completion
September 2026
Sex
Female only
Last updated on clinicaltrials.gov in February 2026.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.